Lupin surges on receiving USFDA’s approval for Ganirelix Acetate Injection
Lupin is currently trading at Rs. 1197.00, up by 3.20 points or 0.27% from its previous closing of Rs. 1193.80 on the BSE. The scrip opened at Rs. 1180.65 and has touched a high and low of Rs. 1211.10 and Rs. 1180.65 respectively. So far 15923 shares were traded on the counter. The BSE group … Read more
